Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor-Positive Breast Cancer: Clinical Versus Molecular Tools.

Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor-Positive Breast Cancer: Clinical Versus Molecular Tools. J Clin Oncol. 2019 Apr 03;:JCO1801933 Authors: Foldi J, O'Meara T, Marczyk M, Sanft T, Silber A, Pusztai L PMID: 30943126 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30943126?dopt=Abstract

Source: Clinical Breast Cancer - April 2, 2019 Category: Cancer & Oncology Authors: Foldi J, O'Meara T, Marczyk M, Sanft T, Silber A, Pusztai L Tags: J Clin Oncol Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology